Cargando…

Corrigendum to “Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer” [Neoplasia 19 (2017) 145-153]

Detalles Bibliográficos
Autores principales:	Park, Ki Cheong, Kim, Seok-Mo, Jeon, Jeong Yong, Kim, Bup-Woo, Kim, Hyeung Kyoo, Chang, HoJin, Lee, Yong Sang, Kim, Soo Young, Choi, Seung Hoon, Park, Cheong Soo, Chang, Hang-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523075/ https://www.ncbi.nlm.nih.gov/pubmed/28739012 http://dx.doi.org/10.1016/j.neo.2017.05.006

Ejemplares similares

Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer
por: Park, Ki Cheong, et al.
Publicado: (2017)

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models
por: Yun, Hyeok Jun, et al.
Publicado: (2021)

Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer
por: Kim, Seok-Mo, et al.
Publicado: (2015)

Diagnostic Thyroidectomy May Be Preferable in Patients With Suspicious Ultrasonography Features After Cytopathology Diagnosis of AUS/FLUS in the Bethesda System
por: Lee, Yong Sang, et al.
Publicado: (2015)

Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
por: Kim, Soo Young, et al.
Publicado: (2019)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
por: Kim, Soo Young, et al.
Publicado: (2018)

Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
por: Kim, Soo Young, et al.
Publicado: (2020)

Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis
por: Lee, Jin-Seok, et al.
Publicado: (2022)

Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment
por: Lee, Haejun, et al.
Publicado: (2020)

The Clinical Significance of the Right Para-Oesophageal Lymph Nodes in Papillary Thyroid Cancer
por: Chang, Hojin, et al.
Publicado: (2015)

Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells()()
por: Lee, Yong Sang, et al.
Publicado: (2018)

Parathyroid score can predict the duration of required calcium supplementation after total thyroidectomy
por: Kim, Bup-Woo, et al.
Publicado: (2017)

On-site ultrasound-guided localization for impalpable nodal recurrences in papillary thyroid carcinoma patients
por: Kim, Kuk-Jin, et al.
Publicado: (2013)

Overcoming the Limitations of Fine Needle Aspiration Biopsy: Detection of Lateral Neck Node Metastasis in Papillary Thyroid Carcinoma
por: Jun, Hak Hoon, et al.
Publicado: (2015)

Ultrasonographic features and clinicopathologic characteristics of macrofollicular variant papillary thyroid carcinoma
por: Lee, Yong Sang, et al.
Publicado: (2018)

Difficult evaluation of thyroid cancer due to cervical paraffin injection
por: Lee, Yong Sang, et al.
Publicado: (2011)

Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up
por: Kim, Soo Young, et al.
Publicado: (2020)

Solitary lateral neck node metastasis in papillary thyroid carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2014)

Anaplastic Thyroid Carcinoma: A Therapeutic Dilemma
por: Chang, Hang-Seok, et al.
Publicado: (2005)

The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells
por: Park, Ki Cheong, et al.
Publicado: (2015)

Tumor Margin Histology Predicts Tumor Aggressiveness in Papillary Thyroid Carcinoma: A Study of 514 Consecutive Patients
por: Kim, Kuk-Jin, et al.
Publicado: (2011)

Aggressiveness of Differentiated Thyroid Carcinoma in Pediatric Patients Younger Than 16 years: A Propensity Score-Matched Analysis
por: Kim, Soo Young, et al.
Publicado: (2022)

Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer
por: Kim, Seok-Mo, et al.
Publicado: (2020)

Prophylactic antibiotics may not be necessary for transoral endoscopic thyroidectomy
por: Lee, Jun Sung, et al.
Publicado: (2022)

New approach of prediction of recurrence in thyroid cancer patients using machine learning
por: Kim, Soo Young, et al.
Publicado: (2021)

Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer
por: Yun, Hyeok Jun, et al.
Publicado: (2023)

Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm
por: Lee, Jin Seok, et al.
Publicado: (2022)

PPARγ Targets-Derived Diagnostic and Prognostic Index for Papillary Thyroid Cancer
por: Kim, Jaehyung, et al.
Publicado: (2021)

Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
por: Chang, Hang-Seok, et al.
Publicado: (2023)

Papillary thyroid cancer in black thyroid: a case report and literature review
por: Kim, Min Jhi, et al.
Publicado: (2023)

Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma
por: Kim, Seok-Mo, et al.
Publicado: (2022)

Cervical bronchogenic cysts mimic metastatic lymph nodes during thyroid cancer surgery
por: Jun, Hak Hoon, et al.
Publicado: (2014)

Retroperitoneal Laparoscopic Ureterolithotomy for Upper Ureter Stones
por: Jeong, Byong Chang, et al.
Publicado: (2006)

Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis
por: Lim, Jin Hong, et al.
Publicado: (2020)

Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer
por: Kim, Yuna, et al.
Publicado: (2023)

Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma
por: Yun, Hyeok Jun, et al.
Publicado: (2021)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

Endometriosis of the appendix
por: Yoon, Jiho, et al.
Publicado: (2014)

Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
por: Lim, Sun Min, et al.
Publicado: (2012)

Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer()()
por: Choi, Kyung Hwa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uj9n7e3nh8tcn9svtie9dck2hn